La radiochirurgia con Cyberknife nei gliomi "high grade"

Translated title of the contribution: Radiosurgery Cyberknife in high grade gliomas

L. Fariselli, L. Bianchi, M. De Santis, L. Brait, A. Bergantin, A. Boiardi, C. Marras, G. Broggi, I. Milanesi

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: to evaluate efficacy of Cyberknife radiosurgery in survival of patients with glioblastoma recurrent. MATERIAL AND METHODS: 15 patients with glioblastoma recurrent were treated with staged radiosurgery in May 2004 - January 2006. The mean KPS was 70. The median prescribed isodose was 75% and the median mean dose was 24 Gy in 3 fractions. RESULTS: The mean survival time is 20 months. No acute toxicity was observed. At 15 months from the date of radiosurgery one case of radionecrosis was detected. CONCLUSIONS: our study population confirms that staged radiosurgery is effective in local treatment of recurrent GBM without major acute toxicities.

Original languageItalian
Pages (from-to)161-164
Number of pages4
JournalRivista Medica
Volume13
Issue number1
Publication statusPublished - Mar 2007

Fingerprint

Radiosurgery
Glioma
Glioblastoma
Survival Rate
Survival
Population
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fariselli, L., Bianchi, L., De Santis, M., Brait, L., Bergantin, A., Boiardi, A., ... Milanesi, I. (2007). La radiochirurgia con Cyberknife nei gliomi "high grade". Rivista Medica, 13(1), 161-164.

La radiochirurgia con Cyberknife nei gliomi "high grade". / Fariselli, L.; Bianchi, L.; De Santis, M.; Brait, L.; Bergantin, A.; Boiardi, A.; Marras, C.; Broggi, G.; Milanesi, I.

In: Rivista Medica, Vol. 13, No. 1, 03.2007, p. 161-164.

Research output: Contribution to journalArticle

Fariselli, L, Bianchi, L, De Santis, M, Brait, L, Bergantin, A, Boiardi, A, Marras, C, Broggi, G & Milanesi, I 2007, 'La radiochirurgia con Cyberknife nei gliomi "high grade"', Rivista Medica, vol. 13, no. 1, pp. 161-164.
Fariselli L, Bianchi L, De Santis M, Brait L, Bergantin A, Boiardi A et al. La radiochirurgia con Cyberknife nei gliomi "high grade". Rivista Medica. 2007 Mar;13(1):161-164.
Fariselli, L. ; Bianchi, L. ; De Santis, M. ; Brait, L. ; Bergantin, A. ; Boiardi, A. ; Marras, C. ; Broggi, G. ; Milanesi, I. / La radiochirurgia con Cyberknife nei gliomi "high grade". In: Rivista Medica. 2007 ; Vol. 13, No. 1. pp. 161-164.
@article{e78442edef8d4de18ec48fd14cc6175f,
title = "La radiochirurgia con Cyberknife nei gliomi {"}high grade{"}",
abstract = "OBJECTIVE: to evaluate efficacy of Cyberknife radiosurgery in survival of patients with glioblastoma recurrent. MATERIAL AND METHODS: 15 patients with glioblastoma recurrent were treated with staged radiosurgery in May 2004 - January 2006. The mean KPS was 70. The median prescribed isodose was 75{\%} and the median mean dose was 24 Gy in 3 fractions. RESULTS: The mean survival time is 20 months. No acute toxicity was observed. At 15 months from the date of radiosurgery one case of radionecrosis was detected. CONCLUSIONS: our study population confirms that staged radiosurgery is effective in local treatment of recurrent GBM without major acute toxicities.",
keywords = "Glioblastoma, Radiosurgery, Survival",
author = "L. Fariselli and L. Bianchi and {De Santis}, M. and L. Brait and A. Bergantin and A. Boiardi and C. Marras and G. Broggi and I. Milanesi",
year = "2007",
month = "3",
language = "Italian",
volume = "13",
pages = "161--164",
journal = "Rivista Medica",
issn = "1127-6339",
publisher = "New Magazine Edizioni S.r.l.",
number = "1",

}

TY - JOUR

T1 - La radiochirurgia con Cyberknife nei gliomi "high grade"

AU - Fariselli, L.

AU - Bianchi, L.

AU - De Santis, M.

AU - Brait, L.

AU - Bergantin, A.

AU - Boiardi, A.

AU - Marras, C.

AU - Broggi, G.

AU - Milanesi, I.

PY - 2007/3

Y1 - 2007/3

N2 - OBJECTIVE: to evaluate efficacy of Cyberknife radiosurgery in survival of patients with glioblastoma recurrent. MATERIAL AND METHODS: 15 patients with glioblastoma recurrent were treated with staged radiosurgery in May 2004 - January 2006. The mean KPS was 70. The median prescribed isodose was 75% and the median mean dose was 24 Gy in 3 fractions. RESULTS: The mean survival time is 20 months. No acute toxicity was observed. At 15 months from the date of radiosurgery one case of radionecrosis was detected. CONCLUSIONS: our study population confirms that staged radiosurgery is effective in local treatment of recurrent GBM without major acute toxicities.

AB - OBJECTIVE: to evaluate efficacy of Cyberknife radiosurgery in survival of patients with glioblastoma recurrent. MATERIAL AND METHODS: 15 patients with glioblastoma recurrent were treated with staged radiosurgery in May 2004 - January 2006. The mean KPS was 70. The median prescribed isodose was 75% and the median mean dose was 24 Gy in 3 fractions. RESULTS: The mean survival time is 20 months. No acute toxicity was observed. At 15 months from the date of radiosurgery one case of radionecrosis was detected. CONCLUSIONS: our study population confirms that staged radiosurgery is effective in local treatment of recurrent GBM without major acute toxicities.

KW - Glioblastoma

KW - Radiosurgery

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=34248140742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248140742&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:34248140742

VL - 13

SP - 161

EP - 164

JO - Rivista Medica

JF - Rivista Medica

SN - 1127-6339

IS - 1

ER -